par Gebhart, Géraldine ;Gamez, Cristina;Holmes, Eileen;Robles Barba, Javier;Garcia, Camilo ;Cortés, Montserrat;de Azambuja, Evandro ;Fauria, Karine;van Dooren, Veerle;Aktan, Gursel;Coccia-Portugal, Maria;Kim, Sung-Bae;Vuylsteke, Peter;Cure, Hervé;Eidtmann, Holger;Baselga, José;Piccart-Gebhart, Martine ;Flamen, Patrick ;Di Cosimo, Serena
Référence The Journal of nuclear medicine, 54, 11, page (1862-1868)
Publication Publié, 2013-11
Référence The Journal of nuclear medicine, 54, 11, page (1862-1868)
Publication Publié, 2013-11
Article révisé par les pairs
Titre: |
|
Auteur: | Gebhart, Géraldine; Gamez, Cristina; Holmes, Eileen; Robles Barba, Javier; Garcia, Camilo; Cortés, Montserrat; de Azambuja, Evandro; Fauria, Karine; van Dooren, Veerle; Aktan, Gursel; Coccia-Portugal, Maria; Kim, Sung-Bae; Vuylsteke, Peter; Cure, Hervé; Eidtmann, Holger; Baselga, José; Piccart-Gebhart, Martine; Flamen, Patrick; Di Cosimo, Serena |
Informations sur la publication: | The Journal of nuclear medicine, 54, 11, page (1862-1868) |
Statut de publication: | Publié, 2013-11 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | 18F-FDG-PET/CT |
anti-HER2 drugs | |
early response assessment | |
MeSH keywords: | Antibodies, Monoclonal, Humanized -- administration & dosage -- therapeutic use |
Antineoplastic Combined Chemotherapy Protocols | |
Breast Neoplasms -- diagnosis -- drug therapy -- metabolism | |
Female | |
Fluorodeoxyglucose F18 -- diagnostic use | |
Humans | |
Neoadjuvant Therapy | |
Positron-Emission Tomography | |
Quinazolines -- administration & dosage -- therapeutic use | |
Receptor, ErbB-2 -- metabolism | |
Time Factors | |
Tomography, X-Ray Computed | |
Treatment Outcome | |
Tumor Markers, Biological -- metabolism | |
Note générale: | SCOPUS: ar.j |
Langue: | Anglais |
Identificateurs: | urn:issn:0161-5505 |
info:doi/10.2967/jnumed.112.119271 | |
info:pii/jnumed.112.119271 | |
info:scp/84890308316 | |
info:pmid/24092940 |